Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications S Harirforoosh, W Asghar, F Jamali Journal of Pharmacy & Pharmaceutical Sciences 16 (5), 821-847, 2013 | 1028 | 2013 |
Enantioselective aspects of drug action and disposition: therapeutic pitfalls F Jamali, R Mehvar, FM Pasutto Journal of pharmaceutical sciences 78 (9), 695-715, 1989 | 539 | 1989 |
Renal adverse effects of nonsteroidal anti-inflammatory drugs S Harirforoosh, F Jamali Expert opinion on drug safety 8 (6), 669-681, 2009 | 354 | 2009 |
Clinical pharmacokinetics of ketoprofen and its enantiomers F Jamali, DR Brocks Clinical pharmacokinetics 19 (3), 197-217, 1990 | 290 | 1990 |
COX-2 selective inhibitors cardiac toxicity: getting to the heart of the matter NM Davies, F Jamali J Pharm Pharm Sci 7 (3), 332-336, 2004 | 174 | 2004 |
Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs F Jamali European Journal of Drug Metabolism and Pharmacokinetics 13 (1), 1-9, 1988 | 170 | 1988 |
Clinical pharmacokinetics of ketorolac tromethamine DR Brocks, F Jamali Clinical pharmacokinetics 23 (6), 415-427, 1992 | 163 | 1992 |
Active ingredient consistency of commercially available glucosamine sulfate products. AS Russell, A Aghazadeh-Habashi, F Jamali The Journal of rheumatology 29 (11), 2407-2409, 2002 | 151 | 2002 |
High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method N Daneshtalab, RZ Lewanczuk, F Jamali Journal of Chromatography B 766 (2), 345-349, 2002 | 150 | 2002 |
Stereoselective pharmacokinetics of ketoprofen in the rat. Influence of route of administration. RT Foster, F Jamali Drug Metabolism and Disposition 16 (4), 623-626, 1988 | 150 | 1988 |
The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review W Asghar, F Jamali Inflammopharmacology 23, 1-16, 2015 | 147 | 2015 |
Stereoselective pharmacokinetics of flurbiprofen in humans and rats F Jamali, BW Berry, MR Tehrani, AS Russell Journal of pharmaceutical sciences 77 (8), 666-669, 1988 | 147 | 1988 |
Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis PR Mayo, K Skeith, AS Russell, F Jamali British journal of clinical pharmacology 50 (6), 605-613, 2000 | 141 | 2000 |
A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA study HERA Study Group The American Journal of Medicine 98 (2), 156-168, 1995 | 134 | 1995 |
Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses RT Foster, F Jamali, AS Russell, SR Alballa Journal of pharmaceutical sciences 77 (1), 70-73, 1988 | 130 | 1988 |
High-performance liquid chromatographic assay of ketoprofen enantiomers in human plasma and urine RT Foster, F Jamali Journal of Chromatography B: Biomedical Sciences and Applications 416, 388-393, 1987 | 126 | 1987 |
Protective effects of angiotensin II interruption: evidence for antiinflammatory actions NJ Dagenais, F Jamali Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 (9 …, 2005 | 113 | 2005 |
Single dose pharmacokinetics and bioavailability of glucosamine in the rat A Aghazadeh-Habashi, S Sattari, F Pasutto, F Jamali J Pharm Pharm Sci 5 (2), 181-184, 2002 | 113 | 2002 |
Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates F Jamali, NN Singh, FM Pasutto, AS Russell, RT Coutts Pharmaceutical research 5, 40-43, 1988 | 113 | 1988 |
Ibuprofen racemate and enantiomers: phase diagram, solubility and thermodynamic studies SK Dwivedi, S Sattari, F Jamali, AG Mitchell International journal of pharmaceutics 87 (1-3), 95-104, 1992 | 107 | 1992 |